abrdn Healthcare Investors (HQH)
18.19
+0.03
(+0.17%)
USD |
NYSE |
Nov 04, 16:00
18.16
-0.03
(-0.16%)
Pre-Market: 20:00
Price Chart
Key Stats
Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
---|---|---|---|
-- | -- | -- | -- |
Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
-- | Upgrade | -- | Upgrade |
Basic Info
Investment Strategy | |
General | |
Security Type | |
Equity Style | |
Fixed Income Style | |
Broad Asset Class | |
Broad Category | |
Category Name | |
Category Index | |
Global Category Name | |
YCharts Categorization | Healthcare Equity |
YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
Prospectus Objective | |
Fund Owner Firm Name |
Prospectus Benchmark Index | |
NASDAQ Biotechnology TR USD | 80.00% |
S&P Composite 1500 Healthcare | 20.00% |
Broad Asset Class Benchmark Index | |
100.0% | |
Manager Tenure | |
Daniel Omstead | 23.10 yrs |
Jason Akus | 0.62 yrs |
Performance Versus Category
Annual Total Returns Versus Peers
As of November 05, 2024.
Asset Allocation
Type | % Net | % Long | % Short |
---|---|---|---|
Cash | -- | -- | -- |
Stock | -- | -- | -- |
Bond | -- | -- | -- |
Convertible | -- | -- | -- |
Preferred | -- | -- | -- |
Other | -- | -- | -- |
Basic Info
Investment Strategy | |
General | |
Security Type | |
Equity Style | |
Fixed Income Style | |
Broad Asset Class | |
Broad Category | |
Category Name | |
Category Index | |
Global Category Name | |
YCharts Categorization | Healthcare Equity |
YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
Prospectus Objective | |
Fund Owner Firm Name |
Prospectus Benchmark Index | |
NASDAQ Biotechnology TR USD | 80.00% |
S&P Composite 1500 Healthcare | 20.00% |
Broad Asset Class Benchmark Index | |
100.0% | |
Manager Tenure | |
Daniel Omstead | 23.10 yrs |
Jason Akus | 0.62 yrs |